Table 2 Participant characteristics
From: Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome
All groups | |||
|---|---|---|---|
Variable | Mean (95% CI) or number (percentage) | ||
Healthy control (n = 150) | Multiple sclerosis (n = 50) | ME/CFS (n = 150) | |
Age (years)** | 42 (39.7–44.3) | 49.4 (43.3–51.4) | 41.6 (39.8–43.5) |
BMI (Kg/m2) | 25.9 (24.9–26.8) | 25.5 (24.3–26.8) | 25.4 (24.6–26.3) |
eGFR (ml/min/1.73 m2) | 82.6 (80.7–84.6) | 80.6 (77.9–83.3) | 82.5 (80.9–84.2) |
C-reactive protein(mg/l) | 3.5(2.1–5.0) | 2.4(1.8–2.9) | 2.8(2.2–3.4) |
Female sex | 65 (65%) | 38 (76%) | 112 (74.6%) |
Current smoking** | 4 (4%) | 13 (26%) | 11 (7.5%) |
ME/CFS cases | ||
|---|---|---|
Variable | Mean (95% CI) or number (percentage) | |
Non-severe cases (n = 100) | Severe cases (n = 50) | |
Age (years) | 41.2 (38.9–43.4) | 42.6 (39.4–45.7) |
BMI (Kg/m2)* | 26.2 (25.2–27.3) | 23.7 (22.4–25.0) |
eGFR (ml/min/1.73 m2)* | 80.5 (78.3–86.2) | 86.7 (84.7–88.6) |
C-reactive protein(mg/l) | 3.1(2.4–3.8) | 2.2(1.4–3.1) |
Female sex | 74 (74%) | 38 (76%) |
Current smoking | 10 (10.3%) | 1 (2%) |